Literature DB >> 10977867

Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature.

J G Wagner1, R A Roth.   

Abstract

Leukocyte trafficking into pulmonary tissue and airspaces is a critical component of the host defense response. Activation and migration of polymorphonuclear leukocytes (PMNs) into lungs also contribute to inflammatory tissue injury and remodeling of tissue architecture. There have been considerable advances in our understanding of the mechanisms that control PMN adhesion and transendothelial migration (TEM). Mechanisms of migration unique to the lungs have been described with regard to the profile of adhesion molecules, cytokines, and chemokines elicited during PMN emigration from blood vessels. This work reviews general mechanisms of TEM of PMNs and discusses the nature of PMN recruitment in several models of airway inflammation that illustrate how various stimuli elicit different responses. Pharmacologic manipulation of adhesive interactions between PMNs and endothelial cells is a current area of research aimed at developing pharmacologic agents to control inflammation during pulmonary and other inflammatory diseases. A summary of some of these agents and their actions is presented.

Entities:  

Mesh:

Year:  2000        PMID: 10977867

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  84 in total

1.  Reconstituting organ-level lung functions on a chip.

Authors:  Dongeun Huh; Benjamin D Matthews; Akiko Mammoto; Martín Montoya-Zavala; Hong Yuan Hsin; Donald E Ingber
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

Review 2.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

3.  Febrile-range hyperthermia modifies endothelial and neutrophilic functions to promote extravasation.

Authors:  Mohan E Tulapurkar; Eid A Almutairy; Nirav G Shah; Ju-ren He; Adam C Puche; Paul Shapiro; Ishwar S Singh; Jeffrey D Hasday
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

4.  Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis.

Authors:  Li Zhang; Shengwei Jin; Changdong Wang; Rong Jiang; Jingyuan Wan
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

5.  Evaluation of oxidative stress in the thrombolysis of pulmonary embolism.

Authors:  Diana Mühl; Réka Füredi; Julia Cristofari; Subhamay Ghosh; Lajos Bogár; Balázs Borsiczki; Balázs Gasz; Elizabeth Roth; János Lantos
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

6.  Aryl hydrocarbon receptor targets pathways extrinsic to bone marrow cells to enhance neutrophil recruitment during influenza virus infection.

Authors:  Sabine Teske; Andrea A Bohn; Jason P Hogaboam; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2007-11-15       Impact factor: 4.849

7.  Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration.

Authors:  Filip Kukulski; Fethia Ben Yebdri; Joanna Lecka; Gilles Kauffenstein; Sébastien A Lévesque; Mireia Martín-Satué; Jean Sévigny
Journal:  Cytokine       Date:  2009-03-19       Impact factor: 3.861

Review 8.  Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.

Authors:  Jarin Chun; Alice Prince
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

9.  Angiostatin inhibits acute lung injury in a mouse model.

Authors:  Gurpreet K Aulakh; Sarabjeet S Suri; Baljit Singh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

10.  Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.

Authors:  Na Young Yi; Donna R Newman; Huiying Zhang; Helena Morales Johansson; Philip L Sannes
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.